Leda Mannent

This inventor holds 6 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Sanofi Biotechnology, Regeneron Pharmaceuticals, Inc., Sanofi. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leda Mannent. Retrieved from https://idiyas.com/inventor/leda-mannent

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 8)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 8)

EPO Patents = 2 (Patent Applications = 11)

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 49(Granted Patents)

Company Filing History:

Regeneron Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2018-2026

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12709642 - METHODS FOR TREATING NASAL POLYPOSIS BY ADMINISTERING AN IL-4R ANTAGONIST (2026-08-18),

2. 12702709 - METHODS FOR TREATING CHRONIC RHINOSINUSITIS WITH NASAL POLYPS BY ADMINISTERING AN ANTIBODY ANTAGONIST OF IL-4R (2026-08-11),

3. 11214621 - Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist (2022-01-04),

4. 11053309 - Methods for treating active eosinophilic esophagitis (2021-07-06),

5. 10066017 - Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist (2018-09-04),

6. 10059771 - Methods for treating nasal polyposis by administering an IL-4R antagonist (2018-08-28),

Title: Leda Mannent: Innovator in Therapeutic Methods

Introduction

Leda Mannent is a prominent inventor based in Paris, France. She has made significant contributions to the field of medicine, particularly in the development of therapeutic methods for various conditions. With a total of four patents to her name, her work has the potential to impact many lives.

Latest Patents

Mannent's latest patents include innovative methods for treating chronic sinusitis with nasal polyps. This invention provides methods for decreasing a nasal polyp score in a subject by administering a therapeutic composition that includes an interleukin-4 receptor (IL-4R) antagonist. Another notable patent focuses on treating active eosinophilic esophagitis. This invention outlines methods for treating, preventing, or reducing the severity of this condition by administering a therapeutic composition that comprises an IL-4/IL-13 pathway inhibitor.

Career Highlights

Throughout her career, Leda Mannent has worked with leading companies in the biotechnology sector, including Sanofi Biotechnology and Regeneron Pharmaceuticals. Her experience in these organizations has allowed her to develop and refine her innovative ideas.

Collaborations

Mannent has collaborated with notable professionals in her field, including Allen Radin and Gianluca Pirozzi. These partnerships have contributed to her success and the advancement of her inventions.

Conclusion

Leda Mannent is a trailblazer in the field of therapeutic innovations, with a focus on addressing significant medical challenges. Her patents reflect her dedication to improving patient outcomes through scientific advancements.

Profile summary based on public USPTO records.